Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Whether such recurrence is less likely after interferon treatment remains the source of some controversy in the hep C research community.
“Truly, I wouldn’t be here today if it weren’t for clinical trials,” she says.
The link between the older interferon treatment and these cancers may be related to the drug’s low hep C cure rate.
Dr. Krim led research on interferon and advocated for treatment access.
Any previous apparent link between direct-acting antivirals, compared with interferon, and liver cancer was likely driven by other factors.
But curing hepatitis C does lower the risk of liver cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.